Live: Rocket Lab Q1 Earnings Tonight – Can RKLB Continue to Soar?
Live Updates
Rocket Lab Q1 Earnings Coverage Wrap-Up
That wraps up our initial coverage of Rocket Lab’s Q1 results. Thank you for stopping by!
Check out management’s earnings call at 5 PM EST for more updates.
Rocket Lab Expands Into Space Robotics With New Motiv Acquisition
Rocket Lab is acquiring Motiv Space Systems, a space robotics company whose technology has already been used on NASA’s Mars Perseverance rover and lunar rover programs.
The acquisition helps Rocket Lab close “one of the final gaps” in its vertical integration strategy by bringing critical spacecraft components in-house, including solar array drive assemblies and precision motion systems that are often supply-constrained.
Rocket Lab’s CEO, Peter Beck, said: “Our acquisition strategy is simple but proven and effective: we identify the best space technologies that have struggled to scale, and we bring them into the Rocket Lab ecosystem.”
The deal also expands Rocket Lab deeper into planetary exploration and national security opportunities while strengthening its ability to manufacture satellites at a constellation scale.
Rocket Lab Says Neutron Demand Is Filling Up Through 2030
Rocket Lab says it just signed “the largest launch contract in Rocket Lab history,” including 5 Neutron launches and 3 Electron launches scheduled through 2029.
The company also highlighted a notable demand signal around Neutron, stating: “With Neutron’s manifest filling up fast through to the end of the decade, the demand signal is clear: the market needs medium launch and assured access to space.”
That comment matters because investors are still debating how large Neutron’s commercial opportunity could become. Rocket Lab is signaling that customer demand is already building years ahead of the rocket’s full operational rollout.
Rocket Lab Expands Deeper Into Missile Defense With Raytheon Partnership
$RKLB announced that Rocket Lab and Raytheon were selected to demonstrate capabilities for the U.S. Space Force’s Space Based Interceptor program, a missile defense initiative focused on countering hypersonic threats.
The announcement adds another layer to Rocket Lab’s defense positioning beyond launches and satellites. Management said the company’s launch and space systems portfolio helped secure the role alongside Raytheon.
Rocket Lab continues to move deeper into national security infrastructure, an area that could become a much larger long-term revenue driver as U.S. defense spending on space and missile defense expands.
Rocket Lab Is Starting to Show Operating Leverage
One underappreciated detail from Rocket Lab’s quarter is that profitability scaled much faster than expected alongside revenue growth.
Q1 revenue rose 63% YoY to $200.3 million, but adjusted gross margin also expanded sharply to 43%, up from 33.4% a year ago. Meanwhile, adjusted EBITDA loss came in at just -$11.8 million versus expectations for roughly -$29 million.
The company also signed the largest launch contract in its history during the quarter, pushing backlog above $2.2 billion.
Rocket Lab Shares Rocket 6% After Q1 Earnings Out
Rocket Lab just reported earnings. Here are the key numbers:
• Revenue: $200M (record quarter)
• Operating Income: -$56.0M
• Net Income: -$45.0M
• Operating Expenses: $132.5M
• Backlog: Over $2.2B
Guidance / Commentary:
• Management said Rocket Lab exceeded all guidance metrics for the quarter, including revenue, gross margin, and adjusted EBITDA.
• The company is also guiding for another record revenue quarter ahead.
Quick read:
• Rocket Lab continues to execute on growth, with record revenue and a backlog that now exceeds $2.2 billion.
• Profitability remains the biggest debate, as the company is still posting sizable operating losses while investing heavily into scale and Neutron development.
Shares are initially up 6% following the report.
Four Wildcards That Could Move Rocket Lab Stock Tonight
Four Wildcards Not in Consensus
Beyond the headline guidance of $185M-$200M revenue and a $21M-$27M adjusted EBITDA loss, several catalysts could swing tonight’s reaction in ways the 65.5% implied beat probability on Polymarket may be underweighting.
- Neutron schedule risk. A stage-1 tank test failure already pushed debut from Q1 2026 to Q4 2026. Any further slip pressures the multiple, while a clean qualification update could send the stock higher.
- Golden Dome optionality. Beyond the $816M Space Development Agency Tranche 3 award, selection for SHIELD carries contracts up to $151B.
- Mynaric integration. The German laser-comms deal adds ITAR and euro FX exposure that most models ignore.
- SpaceX IPO overhang. The competitive threat from the SpaceX IPO is a sentiment risk that guidance might not be accounting for.
Why Rocket Lab's Q1 Guidance Matters More Than Earnings Results
Rocket Lab’s consensus is anchored at -$0.08 EPS and $189 million in revenue, well inside management’s $185 million to $200 million Q1 range.
CEO Peter Beck typically guides conservatively, and Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) has hit or topped the high end for three consecutive quarters, including $179.652 million in Q4 2025.
The swing factors investors want quantified: Q2 2026 revenue, an updated Neutron timeline, backlog progression beyond $1.85 billion, and the adjusted EBITDA trajectory relative to the $21 million to $27 million Q1 loss range.
Bullish Signals: Q2 guidance above $200M, a reaffirmed Q4 2026 Neutron debut, non-GAAP gross margin guide of 42%+, and narrowing EBITDA losses.
Bearish Signals: Q2 below $185M, another Neutron slip, or capex stepping materially higher against FY25’s $156 million base.
Rocket Lab's Guidance Tonight Will Be the Main Story
The Quarter That Has to Bridge the Story
Rocket Lab is now valued at about $48.4 billion, and trades at a multiple that assumes Neutron and defense scale up on schedule.
If management delivers a tight Neutron update, holds margins inside guidance, and converts backlog into recognized revenue, the next leg of the narrative writes itself. Guidance will be really important tonight for the stock.
Investors are watching Rocket Lab (NASDAQ: RKLB) ahead of first-quarter 2026 results due May 7. After a record fourth quarter and a stumble by Neutron, this earnings report will test whether momentum still outweighs execution risk.
Record Backlog Meets a Neutron Setback
Rocket Lab closed 2025 strong. Q4 revenue hit $179.65 million, up 35.7% year over year, with non-GAAP gross margin of 44.3% and an EPS loss of -$0.09, beating the -$0.098 estimate. Full-year revenue reached $601.8 million (+37.96%) on 21 launches with 100% success.
The bigger story is the pipeline. Backlog ended at $1.85 billion, up 73% year over year, anchored by the $816 million Space Development Agency Tranche 3 award. Offsetting that, a stage-1 tank test failure pushed Neutron’s first launch to Q4 2026. Shares have absorbed the news, climbing 16.29% over the past month and 250.36% over the past year.
Q1 2026 Company Guidance
| Metric | Q1 2026 Guidance | Q1 2025 Actual |
|---|---|---|
| Revenue | $185M–$200M (~57% YoY at midpoint) | $122.57M |
| Non-GAAP gross margin | 39%–41% | n/a |
| Adj. EBITDA loss | $21M–$27M | n/a |
| EPS (Q1 2025 ref.) | n/a | -$0.12 |
Polymarket traders price the odds of an earnings beat at 64%.
Neutron, Margins, and Defense Wins
I’ll be watching three things. First, I’ll be looking for an updated timeline for Neutron, along with a capex framework. Cash sits at $828.66 million, but FY2025 free cash flow was -$321.8 million, and capex was $156.3 million. The burn pace matters.
Second, margins. Q4’s 44.3% non-GAAP gross margin set a high bar, and Q1 guidance calls for a step down to 39%–41%. Investors will look at the mix between Space Systems and Launch, as well as how the $325 million Geost acquisition fits into the new Payloads unit.
Third, defense conversion. The SDA Tranche 3 kickoff and SHIELD selection by the Missile Defense Agency positioned Rocket Lab as a prime contractor. Backlog growth from 30+ new launch contracts signed in 2025 should keep flowing.
Sentiment has cooled. Reddit chatter shifted from very bullish in mid-April (sentiment score of 88) to neutral (45–54) as concerns about the SpaceX IPO competition dominated pre-earnings discussion. Analyst consensus target sits at $87.56 with 12 buys and 5 holds.
Thomas Richmond is a financial writer and content strategist with 5+ years of experience covering stocks and financial markets. He has published over 250 articles focused on individual stock analysis, helping investors better understand business fundamentals, stock valuations, and long-term opportunities.
Thomas previously served as a Content Lead at TIKR, a stock research platform, where he helped scale the company’s blog to hundreds of articles per month and contributed to a weekly newsletter reaching more than 100,000 investors.
He specializes in breaking down complex companies into clear, actionable insights for everyday investors, with a focus on fundamentals-driven research.
His work has also been featured on platforms including Seeking Alpha and Sure Dividend.
Outside of work, Thomas enjoys weight lifting and soccer.
© 24/7 Wall St.